跳至主要内容
临床试验/ACTRN12615001031550
ACTRN12615001031550招募中2 期

A Phase II Study for the Treatment of Localised Spine Metastasis: Assessing the Safety and Efficacy of Image Guided Radiosurgery prior to Surgical Stabilisation.

Epworth HealthCare0 个研究点目标入组 20 人开始时间: 2015年10月1日最近更新:

试验速览

阶段
2 期
状态
招募中
发起方
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Non-randomised trial
主要目的
Treatment
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 85 Years(—)
性别
All

入选标准

  • Males or females aged 18 to 85 (inclusive).
  • Histological diagnosis of a non-haematological malignancy.
  • Radiological (MRI or CT within 4 weeks) diagnosis of spinal metastases (C1-L5) who require surgery.
  • TOKUHASHI score of 9 or above.
  • Karnovsky performance score (KPS) > 70%.
  • Maximum involvement of two contiguous spinal levels.
  • Muscle power greater than 3/5.
  • Baseline NRPS greater or equal to 4 assessed within 36 hours prior to registration.
  • Ability to lie supine.
  • Women with child-bearing potential must have a negative serum pregnancy test and practice adequate contraception.

排除标准

  • Participants with rapidly progressive neurological symptoms.
  • Previous irradiation to the same spinal level.
  • Non-ambulatory status.
  • > 2 contiguous vertebral bodies involved.
  • > 2 treatment sites.
  • Predefined spinal cord tolerances cannot be met.
  • Chemotherapy or other systemic treatment <3 weeks prior to SBRT.
  • Taxane or Anthracycline containing chemotherapy < 4 weeks prior to, or concurrent with, SBRT.
  • Contraindications to radiological imaging and surgical intervention.

研究者

发起方
Epworth HealthCare

相似试验

招募中
2 期
Preceding local therapy to STRIDE for pretreated patientsHepatocellular carcinoma
JPRN-jRCT1041230013Yamashita Tatsuya36
进行中(未招募)
1 期
A Phase II Pilot Study to Assess Safety and Efficacy of Sodium Valproate in Adults with McArdle DiseaseMcArdle disease (Glycogen storage disease type V, GSDV). The condition is an inherited disorder of skeletal muscle that causes exercise intolerance. The condition can give way to potential rhabdomyolysis which can cause acute renal failure and from middle age muscle wasting and weakness. Affected patients are unable to produce lactate during ischaemic exercise due to a congenital lack of the enzyme muscle glycogen phosphorylase which is essential for glycogen metabolism.MedDRA version: 16.1 Level: LLT Classification code 10026969 Term: McArdle's disease System Organ Class: 100000004850
EUCTR2012-002933-12-GBniversity College London,8
进行中(未招募)
不适用
A Phase II study in patients with locally advanced pancreatic carcinoma:ARC-II – Akt-inhibition by Nelfinavir plus chemoradiation with gemcitabine and cisplatin - ARC-II in locally advanced pancreatic carcinomaborderline resectable or unresectable pancreatic carcinomaMedDRA version: 14.1Level: PTClassification code 10033611Term: Pancreatic carcinoma non-resectableSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 14.1Level: LLTClassification code 10033600Term: Pancreatic adenocarcinoma non-resectableSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 14.1Level: LLTClassification code 10033606Term: Pancreatic cancer non-resectableSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)
EUCTR2008-006302-42-GBThe University of Oxford49
已完成
2 期
A phase II study of surgical treatment for non-small cell lung cancer patients with distant oligometastaseson-small cell lung cancer with distant oligometastases
JPRN-UMIN000010934Japanese Northern East Area Thoracic Surgery Study Group (JNETS)55
已完成
不适用
ocal HER-O: A study of local therapy for the treatment of brain metastases from Human Epidermal Growth Factor Receptor Type 2 (HER2) positive breast cancer.Metastatic HER2 positive breast cancer - brain metastasesCancer - BreastCancer - Brain
ACTRN12616001265460Trans Tasman Radiation Oncology Research Group (TROG)25
Radiation treatment prior to surgery for local spine... | 临床试验